Ipsen's CEO to leave over "strategic differences"
This article was originally published in Scrip
Executive Summary
Ipsen's chairman and CEO Jean-Luc Bélingard is leaving the company over "strategic differences", said the French pharma firm. The board of directors has appointed Marc de Garidel as the new chairman and CEO, effective 22 November.